Global Allergy and Airways Patient Platform (GAAPP) based in Vienna, Austria, GAAPP’s Board is representative of all regions of the world with large and small groups, all with a common purpose: empowering the patient and supporting the patient voice so that decision makers in both the public and private sectors, in government and industry will be mindful of patient needs, patient desires and patient rights.

Since 2009 GAAPP have grown into a vibrant worldwide organization with more than 60 constituent members from every continent sharing information and best practices, concerns and hopes.

GAAPP’s mission is to globally support and empower patients with allergies, airways and atopic diseases by protecting their rights and insisting on the duties of governments, healthcare professionals and the general public.

GAAPP’s vision is to create a world where patients with allergies, airways and atopic diseases live better. GAAPP operates based on the values of respect, responsibility, and relationships.  

GAAPP’s goals and objectives are based upon the following four pillars: Awareness, Education, Advocacy, and Research.  

• To ensure the growth & sustainability of the Board of Directors & staff to achieve the mission.

• To equip and empower MOs to fulfil their missions. 

• To drive awareness and action to address unmet needs of allergy, asthma, and atopic disease patients. 

• To create & disseminate tailored evidence-based education tools to support patients, caregivers, policymakers, and Health Care Providers. 

• To advocate on behalf of all people living with asthma, allergies, and atopic diseases to receive the best care, at the best time, with the fewest barriers. 

• To advance and ensure the allergy/asthma/atopic disease patient voice in research & development to reflect the full community. 

GAAPP works with healthcare and governmental organizations – such as WHO, EAACI, ERS, GINA, GOLD, WHO GARD, and IPCRG – to improve patients’ lifestyles and reduce the impact of these diseases. Serving as an equal partner, GAAPP can make dynamic, beneficial changes to health and social policy and global decision-making while exchanging information and best practices with our member organizations. GAAPP also strives to improve the quality of diagnosis and therapy within the field. As a global platform, GAAPP aims to serve as an intermediary among patient organizations, enabling the amplification of local voices and encouraging communication across the globe. GAAPP also strives to demand global standards – including an increase in air quality by reducing pollution – that will ultimately empower patients and their communities and improve their lifestyles. GAAPP also supports the establishment of patient organizations in low and middle-income countries, helping improve allergy, airways, and atopic disease care and support worldwide.

GAAPP members benefit from first-hand knowledge and their support for local adaption and implementation of global quality standards.

GAAPP also conducts annual global events like the Scientific Meeting, The Global Food Allergies Summit, and the Global Respiratory Summit granting to their members access to worldwide initiatives and shared decision making, as well as global events and the highest quality of support. This helps their Member Organizations enable your local patients and their healthcare professionals to thrive.